The Verge, May 14, 2015. A company called Cur is developing a promising new pain-relieving product, according to Mashable, Fast Company, and PC World. Problem is, the company is doing it by launching a $50,000 crowdfunding campaign on its own website prior to filing for the necessary FDA clearance. The move could doom the product before it ever hits the market — or it could point to a glaring loophole in FDA regulations.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
2015 Foremother Awards and Health Policy Heroes Luncheon
May 11, 2015. The 2015 Foremother Awards honored Jodie Bernstein and Karen Mulhauser as Foremothers and Dr. Hooman Noorchashm and Dr. Amy Reed as Health Policy Heroes.
Read More »NCHR Honors 2015 Foremothers and Health Policy Heroes
May 5, 2015. Two trailblazing women and a courageous physician couple will be honored by the National Center for Health Research at its 11th annual luncheon at the Cosmos Club on May 8, the Friday before Mother’s Day.
Read More »Long-Term Data on Complications Adds to Criticism of Contraceptive Implant
The New York Times, May 3, 2015. When a new contraceptive implant came on the market over a decade ago, it was considered a breakthrough for women who did not want to have more children, a sterilization procedure that could be done in a doctor’s office in just 10 minutes.
Read More »Bill to Speed Approvals for Drugs Is Cut Back
The New York Times, April 30, 2015. Legislation that would have accelerated the pace of federal drug approvals in a way that critics said threatened to erode patient safety was formally released this week, in a scaled-back version with many of the most controversial provisions left out.
Read More »